Clinical Trial: US-60010-001 NAPOLI3

Trial Status: Closed
Disease Type: Esophageal/Gastric
Trial ID US-60010-001 NAPOLI3
Sponsor ID US-60010-001 NAPOLI3

An open-label, randomised, multicentre, phase III study of irinotecan liposome injection, oxaliplatin, 5-fluorouracil/leucovorin versus nab-paclitaxel plus gemcitabine in subjects who have not previously received chemotherapy for metastatic

Principal Investigator
Keeran R. Sampat, MD

Locations

Alexandria Office

Arlington Office

Fairfax Office

Gainesville Office

Loudoun Office

Learn More About This Trial
Other Relevant Trials
Trial ID D910GC00001
Sponsor ID Matterhorn

A Randomized, Double Blind, Placebo-Controlled, Phase III Study of Neoadjuvant-Adjuvant Durvalumab and FLOT Chemotherapy in Patients with Resectable Gastric and GE Junction Cancer

Trial ID PCS6422G1-01
Sponsor ID Processa

A Phase 1b Dose-Escalation Study of the Safety and Pharmacokinetics of Fixed-Dose PCS6422 with Escalating Doses of Capecitabine Administered Orally to Patients with Advanced, Refractory Gastrointestinal Tract Tumors